The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kovrazhkina E.A.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet;
NII tserebrovaskuliarnoĭ patologii i insul'ta, Moskva

Stakhovskaya L.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Razinskaia O.D.

Serdyuk A.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Inhibitors of CNS regeneration, their physiological role and participation in pathogenesis of diseases

Authors:

Kovrazhkina E.A., Stakhovskaya L.V., Razinskaia O.D., Serdyuk A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5): 143‑149

DOI: 10.17116/jnevro201811851143

Read: 11842 times

Download PDF (RU)
Contact the author
Table of contents

INHIBITORS OF CNS REGENERATION, THEIR PHYSIOLOGICAL ROLE AND PARTICIPATION IN PATHOGENESIS OF DISEASES
INHIBITORS OF CNS REGENERATION, THEIR PHYSIOLOGICAL ROLE AND PARTICIPATION IN PATHOGENESIS OF DISEASES

To cite this article:

Kovrazhkina EA, Stakhovskaya LV, Razinskaia OD, Serdyuk AV. Inhibitors of CNS regeneration, their physiological role and participation in pathogenesis of diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5):143‑149. (In Russ.)
https://doi.org/10.17116/jnevro201811851143

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Prognostic significance of uromodulin in contrast-induced nephropathy: a systematic review. Russian Journal of Preventive Medi­cine. 2026;(4):103-109
Abstract:

The review is devoted to axon growth inhibitors in the CNS, including a physiological role of myelin-associated proteins (Nogo-A, MAG, OMgp) and their involvement in the pathogenesis of various diseases (spinal injuries, stroke, neurodegenerations).

Keywords:

central nervous system
Wallerian degeneration
axons
myelin-associated axon growth inhibitors
small GTPases
RoA
Nogo-A
MAG
OMgp

Authors:

Kovrazhkina E.A.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet;
NII tserebrovaskuliarnoĭ patologii i insul'ta, Moskva

Stakhovskaya L.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Razinskaia O.D.

Serdyuk A.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Close metadata

References:

  1. Borshchenko IA, Baskov AV, Korshunov AG, Satanova FS. Some aspects of the pathophysiology of traumatic injury, and spinal cord regeneration. Questions of Neurosurgery. 2000;2. (In Russ.)
  2. Neuroprotection: models, mechanisms and therapy. Ed. Baer; trans. From English. BINOM; 2011. (In Russ.)
  3. Schwaiger F, Hager G, Schmitt A, Horvat A, Hager G, Streif R, Spitzer C, Gamal S, Breuer S, Brook GA, Nacimiento W, Kreutzberg GW. Peripheral but not central axonotomy induces changes in Janus kinases (JAK) and signal transduces and activators of transcription (STAT). Eur J Neurosci. 2000;12:1165-1176.
  4. Gianola S, Rossi F. Evolution of the Purkije cell resronse to injuri and regenerative potential during postnatal development of the rat cerebellum. J Comp Neurol. 2001;430:101-117.
  5. Steeves J, Keirstead H, Ethell D, Hasan SJ, Muir GD, Pataky DM, McBride CB, Petrausch B, Zwimpfer TJ. Permissive and restrictive periods for brainstem-spinal regeneration in the chick. Prog Brain Res. 1994;103:243-262.
  6. Akbik F, Cafferty WB, Strittmatter SM. Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol. 2012;235(1):43-52.
  7. Kadomatsu K, Sakamoto K. Mechanisms of axon regeneration and its inhibition: roles of sulfated glycans. Arch Biochem Biophys. 2014;558:36-41.
  8. Chan CC, Khodarahmi K, Liu J, Sutherland D, Oschipok LW, Steeves JD, Tetzlaff W. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp Neurol. 2005;196(2):352-364.
  9. Wu BQ, Bi ZG, Qi Q. Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats. Chin Med J (Engl). 2013;126(19):3723-3727.
  10. Fujita Y, Yamashita T. Axon growth inhibition by RhoA/ROCK in the central nervous system. Front Neurosci. 2014;8:338.
  11. Baldwin KT, Giger RJ. Insights into the physiological role of CNS regeneration inhibitors. Front Mol Neurosci. 2015;8:23.
  12. Vorotnikov AV. Chemotaxis: movement, direction, management. Advances of Biological Chemistry. 2011;51:335-400. (In Russ.)
  13. Allal C, Favre G, Couderc B, Salicio S, Sixou S, Hamilton A, Sebti S, Lajoie-Mazenc I, Pradines A. RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem. 2000;275:31001-31008.
  14. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273(5272):245-248.
  15. Shepelev MV, Chernoff J, Korobko IV. Rho family GTPase Chp/RhoV induces PC12 apoptotic cell death via JNK activation. Small GT Pases. 2011;2(1):17-26.
  16. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002;105(13):1545-1547.
  17. Pruitt K, Der C. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 2001;171:1-10.
  18. Kilinc D, Blasiak A, O’Mahony JJ, Lee GU. Low piconewton towing of CNS axons against diffusing and surfacebound repellents requires the inhibition of motor protein-associated pathways. Sci Rep. 2014;4:7128.
  19. Kubo T, Hata K, Yamaguchi A, Yamashita T. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration. Curr Pharm Des. 2007;13(24):2493-2499.
  20. Schwab M, Thoenen H. Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J Neurosci. 1985;5:2415-2423.
  21. Schwab M, Bartholdi D. Degeneration and regeneration axons in the lesioned spinal cord. Physiol Rev. 1996;76:319-370.
  22. Caroni P, Schwab M. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1988;1:85-96.
  23. Peresedova AV, Zavalishin IA. Compensatory mechanisms in multiple sclerosis (review). Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2013;113(2):17-22. (In Russ.)
  24. Bandtlow C, Schmidt M, Hassinger T, Schwab M, Kater S. Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones. Science. 1993;259:80-83.
  25. Bregman B, Kunkel-Bagden E, Schnell L, Dai H, Gao D, Schwab M. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 1995;378:498-501.
  26. Kim J, Li S, Grandpre T, Qiu D, Strittmatter S. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron. 2003;38:187-199.
  27. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, van der Putten M, Schwab M. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron. 2003;38:201-211.
  28. Zheng B, Ho C, Li S, Keirstead H, Steward O, Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron. 2003;38:213-224.
  29. Filbin M. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci. 2003;4:703-713.
  30. McKerracher L, David S, Jackson D, Kottis V, Dunn R, Braun P. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 1994;13:805-811.
  31. McKerracher L, Rosen KM. MAG, myelin and overcoming growth inhibition in the CNS. Front Mol Neurosci. 2015;8:51.
  32. He X, Bazan J, McDermott G, Park J, Wang K, Tessier-Lavigne M, He Z, Garcia K. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron. 2003;38:177-185.
  33. Wang K, Kim J, Sivasankaran R, Segal R, He Z. P75 interacts with receptor as a co-receptor for Nogo, MAG, and OMgp. Nature. 2002;420:74-78.
  34. Wang X, Chun S, Treloar H, Vartanian T, Greer C, Strittmatter S. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci. 2002;22:5505-5515.
  35. Fournier A, Grandpre T, Strittmatter S. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001;409:341-346.
  36. Fournier A, Takizawa B, Strittmatter S. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci. 2003;23:1416-1423.
  37. Tatsumi E, Yamanaka H, Kobayashi K, Yagi H, Sakagami M, Noguchi K. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain. Glia. 2015;63(2):216-228.
  38. Saab AS, Tzvetanova ID, Nave KA. The role of myelin and oligodendrocytes in axonal energy metabolism. Curr Opin Neurobiol. 2013;23:1065-1072.
  39. Hines JH, Ravanelli AM, Schwindt R, Scott EK, Appel B. Neuronal activity biases axon selection for myelination in vivo. Nat Neurosci. 2015;18:683-689.
  40. Wake H, Lee PR, Fields RD. Control of local protein synthesis and initial events in myelination by action potentials. Science. 2011;333:1647-1651.
  41. Holtmaat A, Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci. 2009;10:647-658.
  42. Mironova YA, Giger RJ. Where no synapses go: gatekeepers of circuit remodeling and synaptic strength. Trends Neurosci. 2013;36:363-373.
  43. Zagrebelsky M, Korte M. Maintaining stable memory engrams: new roles for Nogo-A in the CNS. Neuroscience. 2014;283:17-25.
  44. McGee AW, Yang Y, Fischer QS, Daw NW, Strittmatter SM. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science. 2005;309:2222-2226.
  45. Raiker SJ, Lee H, Baldwin KT, Duan Y, Shrager P, Giger RJ. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity. J Neurosci. 2010;30:12432-12445.
  46. Sala C, Segal M. Dendritic spines: the locus of structural and functional plasticity. Physiol Rev. 2014;94:141-188.
  47. Lee H, Raiker SJ, Venkatesh K, Geary R, Robak LA, Zhang Y, Yeh HH, Shrager P, Giger RJ. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci. 2008;28:2753-2765.
  48. van Gaalen MM, Relo AL, Mueller BK, Gross G, Mezler M. NOGO-66 receptor deficient mice show slow acquisition of spatial memory task performance. Neurosci Lett. 2012;510:58-61.
  49. Vanguilder HD, Bixler GV, Sonntag WE, Freeman WM. Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem. 2012;121:77-98.
  50. Tews B, Schonig K, Arzt ME, Clementi S, Rioult-Pedotti MS, Zemmar A, Berger SM, Schneider M, Enkel T, Weinmann O, Kasper H, Schwab ME, Bartsch D. Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci USA. 2013;110:6583-6588.
  51. Willi R, Schwab ME. Nogo and Nogo receptor: relevance to schizophrenia? Neurobiol Dis. 2013;54:150-157.
  52. Stahel PF, VanderHeiden T, Finn MA. Management strategies for acute spinal cord injury: current options and future perspectives. Curr Opin Crit Care. 2012;18(6):651-660.
  53. Lang BT, Cregg JM, DePaul MA, Tran AP, Xu K, Dyck SM, Madalena KM, Brown BP, Weng YL, Li S, Karimi-Abdolrezaee S, Busch SA, Shen Y, Silver J. Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury. Nature. 2015;518(7539):404-408.
  54. Mar FM, da Silva TF, Morgado MM, Rodrigues LG, Rodrigues D, Pereira MI, Marques A, Sousa VF, Coentro J, Sá-Miranda C, Sousa MM, Brites P. Myelin lipids inhibit axon regeneration following spinal cord injury: a novel perspective for therapy. Mol Neurobiol. 2016;53(2):1052-1064.
  55. McKerracher L, Guertin P. Rho as a target to promote repair: translation to clinical studies with cethrin. Curr Pharm Des. 2013;19(24):4400-4410.
  56. Siegel CS, Fink KL, Strittmatter SM, Cafferty WB. Plasticity of intact rubral projections mediates spontaneous recovery of function after corticospinal tract injury. J Neurosci. 2015;35(4):1443-1457.
  57. Leibscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, Fouad K, Mir A, Rausch M, Kindler D, Hamers FP, Schwab ME. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol. 2005;58:706-719.
  58. Mezler M, Moeller A, Mueller B, Meyer A, Schmidt M, Ghayur T, Barlow E, Labkovsky B, Devanarayan V, Norrell J, Mueller R. Blocking Nogo Receptor 1 promotes functional regeneration after spinal cord injury. J Neurol Disord. 2013;1:3.
  59. Wang JW, Yang JF, Ma Y, Hua Z, Guo Y, Gu XL, Zhang YF. Nogo-A expression dynamically varies after spinal cord injury. Neural Regen Res. 2015;10(2):225-229.
  60. Burke RE, O’Malley K. Axon degeneration in Parkinson’s disease. Exp Neurol. 2013;246:72-83.
  61. Liu FT, Yang YJ, Wu JJ, Li S, Tang YL, Zhao J, Liu ZY, Xiao BG, Zuo J, Liu W, Wang J. Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T α-synuclein by activating the JNK 1/Bcl-2/beclin 1 pathway. Brain Res. 2016;1632:9-18.
  62. Saal KA, Galter D, Roeber S, Bähr M, Tönges L, Lingor P. Altered expression of growth associated protein-43 and Rho-kinase in human patients with Parkinson’s disease. Brain Pathol. 2017;27(1):13-25.
  63. Takata M, Tanaka H, Kimura M, Nagahara Y, Tanaka K, Kawasaki K, Seto M, Tsuruma K, Shimazawa M, Hara H. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol. 2013;170(2):341-351.
  64. Tönges L, Günther R, Suhr M, Jansen J, Balck A, Saal KA, Barski E, Nientied T, Götz AA, Koch JC, Mueller BK, Weishaupt JH, Sereda MW, Hanisch UK, Bähr M, Lingor P. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia. 2014;62(2):217-232.
  65. Barbay S, Plautz EJ, Zoubina E, Frost SB, Cramer SC, Nudo RJ. Effects of postinfarct myelin-associated glycoprotein antibody treatment on motor recovery and motor map plasticity in squirrel monkeys. Stroke. 2015;46(6):1620-1625.
  66. Liu YH, Zhao Y, Huang FZ, Chen YH, Wang HX, Bonney E, Liu BQ. Combination of early constraint-induced movement therapy and fasudil enhances motor recovery after ischemic stroke in rats. Int J Neurosci. 2016;126(2):168-173.
  67. Vajda F, Jordi N, Dalkara D, Joly S, Christ F, Tews B, Schwab ME, Pernet V. Cell type-specific Nogo-A gene ablation promotes axonal regeneration in the injured adult optic nerve. Cell Death Differ. 2015;22(2):323-335.
  68. Forgione N, Fehlings MG. Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg. 2014;82(3-4):535-539.
  69. Watzlawick R, Sena ES, Dirnagl U, Brommer B, Kopp MA, Macleod MR, Howells DW, Schwab JM. Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis. JAMA Neurol. 2014;71(1):91-99.
  70. Sun Z, Dai X, Li Y, Jiang S, Lou G, Cao Q, Hu R, Huang Y, Su Z, Chen M, Luo H, Lin X, Sun J, Xiao F. A novel Nogo-66 receptor antagonist peptide promotes neurite regeneration in vitro. Mol Cell Neurosci. 2016;71:80-91.
  71. Schwab M. Nogo and axon regeneration. Current Opinion in Neurobiology. 2004;14:118-124.
  72. Dergham P, Ellezam B, Essagian C, Adevissian H, Lubell W, McKerracher L. Rho signaling pathway targeted to promotespinal cord repair. J Neurosci. 2002;22:6570-6577.
  73. Filbin MT. PirB, a second receptor for the myelin inhibitors of axonal regeneration Nogo66, MAG, and OMgp: implications for regeneration in vivo. Neuron. 2008;60:740-742.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.